http://rdf.ncbi.nlm.nih.gov/pubchem/reference/29588246

Outgoing Links

Predicate Object
contentType Comparative Study|Journal Article|Meta-Analysis|Research Support, N.I.H., Extramural
endingPage 696
issn 1476-5551
0887-6924
issueIdentifier 4
pageRange 689-696
publicationName Leukemia
startingPage 689
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_39d32cf3094cc69b76fca460ad34a7d1
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_9f9269ac3fdba18bf6689be9810035cc
bibliographicCitation Kapoor P, Rajkumar SV, Dispenzieri A, Gertz MA, Lacy MQ, Dingli D, Mikhael JR, Roy V, Kyle RA, Greipp PR, Kumar S, Mandrekar SJ. Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant ineligible patients with multiple myeloma: a meta-analysis. Leukemia. 2011 Apr;25(4):689–96. doi: 10.1038/leu.2010.313. PMID: 21233832.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_62a0011074d760dfacd2d947284ad74d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_16d100f8e0a1cf7dee582553da320995
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_24dcb31cd0fe84edfc450fd2ab015eb1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_659f5195bfdd3ac2ba62fdf8172f51e6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_83b3a7c5fb6701040444f9ddf0029c14
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_211222f58c430d7339f505cf8c17e25f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2da7ab3310f92696c768252b91c9fc8e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d76e0314c4f187c54aed0625f7011a87
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_def96a80c7abcef7c706eada42e85d11
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_249f4e866d16029ec7cda1a71fb65dde
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_21d2bcb7cd76317321f373b6ef236338
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4887f37b36dccec3e08ee4fafefa45fd
date 2011-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/21233832
https://doi.org/10.1038/leu.2010.313
isPartOf https://portal.issn.org/resource/ISSN/1476-5551
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5536
https://portal.issn.org/resource/ISSN/0887-6924
language English
source https://www.crossref.org/
https://scigraph.springernature.com/
https://pubmed.ncbi.nlm.nih.gov/
title Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant ineligible patients with multiple myeloma: a meta-analysis
discusses http://id.nlm.nih.gov/mesh/M0021267
http://id.nlm.nih.gov/mesh/M0017465
http://id.nlm.nih.gov/mesh/M0013330
hasSubjectTerm http://purl.org/au-research/vocabulary/anzsrc-for/2008/11
http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8530
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5865
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10516
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8854
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5426
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8561
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID460612

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717275
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129356432

Total number of triples: 50.